Tarceva: Oral tablet (100mg)

Detailed Information

ON THIS PAGE:
What is this Medicine?
In-Depth Information
Learn More
Patient Experiences

Also see:

Get answers to Frequently Asked Questions (FAQs)
Find other class related drugs
Find additional patient usage statistics

Visit Drug Summary Page

Check Drug Interactions

Tarceva 100mg Tab
Genentech Inc

Pill Identification: T 100

What is this Medicine?

ERLOTINIB (er LOE ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat non-small cell lung cancer and pancreatic cancer.

In-Depth Information

Tarceva 100mg Tablet

NDC: 502420063

Prescription Required
Not a Controlled Drug
(CSA Schedule)
FDA Approved

FDA approved for the following conditions:
Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer

Sometimes used for but not FDA approved for the following conditions:
Head And Neck Cancer

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F

Tarceva 100mg Tablet

Genentech Inc

Pill Identification: T 100

Shape: round

Color: white

Ingredients

Close All Sections

Reported Side Effects for Tarceva 100mg Tablet

Bowel Obstruction Incidence: <5.0%* Severity: SEVERE
Onset: DELAYED

High Bilirubin Level Incidence: <4.0%* Severity: MODERATE
Onset: DELAYED

Eye Inflammation Incidence: <1.0%* Severity: SEVERE
Onset: DELAYED

Inflamed Pancreas Incidence: <5.0%* Severity: SEVERE
Onset: DELAYED

Fainting Incidence: <5.0%* Severity: MILD
Onset: EARLY

Low Platelet Count Incidence: 0.8%* Severity: MODERATE
Onset: DELAYED

Hemolytic Anemia Incidence: 0.8%* Severity: SEVERE
Onset: DELAYED

Elevated Hepatic Enzymes Incidence: 1.0-4.0%* Severity: MODERATE
Onset: DELAYED

Brain Attack Incidence: 2.3%* Severity: SEVERE
Onset: EARLY

Heart Attack Incidence: 2.3%* Severity: SEVERE
Onset: DELAYED

Weight Loss Incidence: 3.9%* Severity: MILD
Onset: DELAYED

Dry Skin Incidence: 4.4-12.0%* Severity: MILD
Onset: DELAYED

Drug-Induced Acne Incidence: 4.6%* Severity: MILD
Onset: DELAYED

Acne Incidence: 6.2%* Severity: MILD
Onset: DELAYED

Itching Incidence: 7.4-13.0%* Severity: MILD
Onset: RAPID

Tired Incidence: 9.0-52.0%* Severity: MILD
Onset: EARLY

Decreased Appetite Incidence: 9.2-52.0%* Severity: MILD
Onset: DELAYED

Stomach Pain Incidence: 11.0%* Severity: MILD
Onset: EARLY

Blood Clot Incidence: 11.0%* Severity: SEVERE
Onset: DELAYED

Inflamed Eye Incidence: 12.0%* Severity: SEVERE
Onset: EARLY

Conjunctivitis Incidence: 12.0%* Severity: MODERATE
Onset: DELAYED

Gas Incidence: 13.0%* Severity: MILD
Onset: EARLY

Nerve Pain Incidence: 13.0%* Severity: MODERATE
Onset: DELAYED

Nervousness Incidence: 13.0%* Severity: MILD
Onset: DELAYED

Hair Loss Incidence: 14.0%* Severity: MILD
Onset: DELAYED

Headache Incidence: 15.0%* Severity: MILD
Onset: EARLY

Inability To Sleep Incidence: 15.0%* Severity: MILD
Onset: EARLY

Lightheadedness Incidence: 15.0%* Severity: MILD
Onset: EARLY

Mouth Sores Incidence: 17.0%* Severity: MODERATE
Onset: DELAYED

Mouth Ulcers Incidence: 17.0%* Severity: MODERATE
Onset: DELAYED

Upset Stomach Incidence: 17.0%* Severity: MILD
Onset: EARLY

Depression Incidence: 19.0%* Severity: MODERATE
Onset: DELAYED

Loose Stools Incidence: 20.3-54.0%* Severity: MILD
Onset: EARLY

Muscle Pain Incidence: 21.0%* Severity: MILD
Onset: EARLY

Vomiting Incidence: 23.0%* Severity: MILD
Onset: EARLY

Infection Incidence: 24.0%* Severity: MILD
Onset: DELAYED

Bone Pain Incidence: 25.0%* Severity: MODERATE
Onset: DELAYED

Constipation Incidence: 31.0%* Severity: MODERATE
Onset: DELAYED

Cough Incidence: 33.0%* Severity: MILD
Onset: DELAYED

Upset Stomach Incidence: 33.0%* Severity: MILD
Onset: EARLY

Fever Incidence: 36.0%* Severity: MILD
Onset: EARLY

Swelling Incidence: 37.0%* Severity: MODERATE
Onset: DELAYED

Shortness Of Breath Incidence: 41.0%* Severity: MODERATE
Onset: EARLY

Skin Rash Incidence: 49.2-75.0%* Severity: MILD
Onset: EARLY

*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.

Daily Life Interactions for Tarceva 100mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Close All Interactions

Major Lifestyle Interaction

Tobacco and Tarceva 100mg Tablet(Erlotinib)

Tobacco and Erlotinib(Erlotinib)

Tobacco smoke contains substances that may speed the removal of Erlotinib from the body. If you start smoking, Erlotinib may become less effective. If you stop smoking, the amount of Erlotinib in the blood may increase and side effects from Erlotinib may get worse. Tell your health care professional if you smoke or if you are going to stop smoking.

Moderate Lifestyle Interaction

Grapefruit juice and Tarceva 100mg Tablet(Erlotinib)

Grapefruit juice and Erlotinib(Erlotinib)

It is recommended that you avoid or limit grapefruit-juice or grapefruit-containing foods during treatment with Erlotinib. Grapefruit products may increase the levels of Erlotinib and your risk for side effects. Notify your health care provider if you notice increased eye irritation and/or pain, shortness of breath or difficulty breathing, nausea, vomiting, mouth sores, or other unusual effects.

Check Drug Interactions

Pregnancy & Lactation Information

FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

THIRD Trimester